Reversing the effects of androgen-deprivation therapy in men with metastatic castration-resistant prostate cancer.
Publication/Presentation Date
9-1-2021
Abstract
OBJECTIVE: To investigate whether bipolar androgen therapy (BAT), involving rapid cyclic administration of high-dose testosterone, as a novel treatment for metastatic castration-resistant prostate cancer (mCRPC) promotes improvements in body composition and associated improvements in lipid profiles and quality of life.
PATIENTS AND METHODS: Men from two completed trials with computed tomography imaging at baseline and after three cycles of BAT were included. Cross-sectional areas of psoas muscle, visceral and subcutaneous fat were measured at the L3 vertebral level. Functional Assessment of Chronic Illness Therapy - Fatigue questionnaire and 36-item short-form health survey were used to assess quality of life.
RESULTS: The 60 included patients lost a mean (sd) of 7.8 (8.2)% of subcutaneous fat, 9.8 (18.2)% of visceral fat, and gained 12.2 (6.7)% muscle mass. Changes in subcutaneous and visceral fat were positively correlated with each other (Spearman's correlation coefficient 0.58, 95% confidence interval 0.35-0.71) independent of the effects of age, body mass index, and duration of androgen-deprivation therapy. Energy, physical function, and measures of limitations due to physical health were all significantly improved at 3 months. The improvements in body composition were not correlated with decreases in lipid levels or observed improvements in quality of life.
CONCLUSIONS: In the present study, BAT was associated with significant improvements in body composition, lipid parameters, and quality of life. This has promising implications for the long-term health of men with mCRPC.
Volume
128
Issue
3
First Page
366
Last Page
373
ISSN
1464-410X
Published In/Presented At
Marshall, C. H., Tunacao, J., Danda, V., Tsai, H. L., Barber, J., Gawande, R., Weiss, C. R., Denmeade, S. R., & Joshu, C. (2021). Reversing the effects of androgen-deprivation therapy in men with metastatic castration-resistant prostate cancer. BJU international, 128(3), 366–373. https://doi.org/10.1111/bju.15408
Disciplines
Diagnosis | Medicine and Health Sciences | Other Analytical, Diagnostic and Therapeutic Techniques and Equipment | Radiology
PubMedID
33765326
Department(s)
Department of Radiology and Diagnostic Medical Imaging
Document Type
Article